Suchergebnisse - "Sanadgol, Nima"

PubPharm (113)

1

Unveiling the Impact of Microglial Cells in Alzheimer's Disease Pathogenesis: Insights from Single-Cell RNA-seq Analysis and In Vivo Validation

enthalten in: ResearchSquare.com | 2024

von Sanadgol, N. | Feriz, A. | Ravanjoo, L. | +4

2

Putative role of glial cells in treatment resistance depression : An updated critical literation review and evaluation of single-nuclei transcriptomics data

enthalten in: Life sciences | 2023

von Sanadgol, N. | Miraki Feriz, A. | Lisboa, S. | +1

3

Presenilin-1-Derived Circular RNAs : Neglected Epigenetic Regulators with Various Functions in Alzheimer's Disease

enthalten in: Biomolecules | 2023

von Sanadgol, N. | Amini, J. | Beyer, C. | +1

4

TNF-α/STAT1/CXCL10 mutual inflammatory axis that contributes to the pathogenesis of experimental models of multiple sclerosis : A promising signaling pathway for targeted therapies

enthalten in: Cytokine | 2023

von Rahmat-Zaie, R. | Amini, J. | Haddadi, M. | +3

5

Lipocalin-2 Deficiency Diminishes Canonical NLRP3 Inflammasome Formation and IL-1β Production in the Subacute Phase of Spinal Cord Injury

enthalten in: International journal of molecular sciences | 2023

von Müller, N. | Scheld, M. | Voelz, C. | +9

6

The interplay between tauopathy and aging through interruption of UPR/Nrf2/autophagy crosstalk in the Alzheimer's disease transgenic experimental models

enthalten in: The International journal of neuroscience | 2023

von Amini, J. | Sanchooli, N. | Milajerdi, M. | +3

7

MAPK Is a Mutual Pathway Targeted by Anxiety-Related miRNAs, and E2F5 Is a Putative Target for Anxiolytic miRNAs

enthalten in: Biomolecules | 2023

von Amini, J. | Beyer, C. | Zendedel, A. | +1

8

Editorial : Glial cells as an emerging therapeutic target in the pathobiology of central nervous system disorders: friend or foe?

enthalten in: Frontiers in cellular neuroscience | 2023

von Sanadgol, N.

9

Prophylactic effects of cucurbitacin B in the EAE Model of multiple sclerosis by adjustment of STAT3/IL-23/IL-17 axis and improvement of neuropsychological symptoms

enthalten in: Metabolic brain disease | 2022

von Reiszadeh-Jahromi, S. | Haddadi, M. | Mousavi, P. | +1

10

Prophylactic effects of cucurbitacin B in the EAE Model of multiple sclerosis by adjustment of STAT3/IL-23/IL-17 axis and improvement of neuropsychological symptoms

enthalten in: Metabolic brain disease | 2022

von Reiszadeh-Jahromi, S. | Haddadi, M. | Mousavi, P. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]